DTL
LGND icon

Dynamic Technology Lab’s Ligand Pharmaceuticals LGND Stock Holding History

Dynamic Technology Lab’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,130
Closed -$214K – 1036
2025
Q4 		$214K Buy
+1,130
New +$217K 0.05% 604
2020
Q4 		– Sell
-6,827
Closed -$406K – 1182
2020
Q3 		$406K Buy
+6,827
New +$466K 0.07% 540
2019
Q1 		– Sell
-5,931
Closed -$502K – 1176
2018
Q4 		$502K Buy
+5,931
New +$632K 0.09% 400
2018
Q3 		– Sell
-1,946
Closed -$251K – 1196
2018
Q2 		$251K Sell
1,946
-300
-13% -$33.5K 0.04% 764
2018
Q1 		$231K Buy
+2,246
New +$222K 0.03% 834

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Dynamic Technology Lab's LGND Position: Q1 2026 in Review

Dynamic Technology Lab sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 1,130 shares — an estimated $214K sold.

Dynamic Technology Lab first reported a position in LGND in Q1 2018 and held it in 5 quarters. The position peaked at $502K in Q4 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Dynamic Technology Lab reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,130 Ligand Pharmaceuticals shares in Q1 2026, an estimated $214K.
  • Dynamic Technology Lab first reported a position in Ligand Pharmaceuticals in Q1 2018 and held it in 5 quarters.
  • Dynamic Technology Lab's Ligand Pharmaceuticals position peaked at $502K in Q4 2018.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.